ALFA Filings
Every announcement, straight from the exchange
Every Nectar Lifesciences other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Nectar Lifesciences Ltd has filed its quarterly shareholding pattern as per SEBI regulations. The document details the promoter group and public shareholding for the quarter.
Nectar Lifesciences Limited announced a change in its corporate office address, moving to Godrej Eternia in Chandigarh effective September 15, 2026.
Nectar Lifesciences shifted its registered office within Dera Bassi, Punjab. This administrative change does not affect the company's operations or statutory registrations.
Nectar Lifesciences Ltd submitted its Annual Secretarial Compliance Report for FY2026. The report highlighted a ₹0.02 Crore fine paid to exchanges for a past delay in filing FY2025 financial results due to the Chairman's health. The auditor confirmed the company has since rectified the default and complied with other SEBI regulations.
Nectar Lifesciences Limited submitted a compliance certificate under Regulation 74(5) for the quarter ended March 31, 2026. The certificate from KFin Technologies confirms that security certificates received for dematerialization were processed and mutilated within prescribed timelines. This is a routine administrative filing with no direct financial impact.